当前位置:首页 - 行情中心 - 联影医疗(688271) - 财务分析

联影医疗

(688271)

  

流通市值:830.62亿  总市值:1153.82亿
流通股本:5.93亿   总股本:8.24亿

联影医疗(688271)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润6.58亿元,每股收益0.82元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益1923537.68万元,未分配利润459291.47万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产2602967.56万元,负债679429.88万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入6,954,283,174.555,333,486,253.172,350,478,362.1111,410,765,602.39
营业总成本6,608,289,860.414,564,826,089.382,055,132,564.469,857,946,495.53
营业利润717,189,637.11,040,259,019.54400,407,296.572,141,515,233.99
利润总额711,860,169.871,039,797,817.14399,740,540.922,142,254,673.91
净利润658,389,509.9944,565,326.24361,942,371.761,977,754,806.44
其他综合收益-7,857,195.812,233,137.291,045,318.2613,750,597.25
综合收益总额650,532,314.09946,798,463.53362,987,690.021,991,505,403.69
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计19,589,025,466.1520,743,243,013.7419,770,733,478.2620,227,806,280.02
非流动资产合计6,440,650,144.25,961,278,258.365,577,015,819.115,108,334,041.94
资产总计26,029,675,610.3526,704,521,272.125,347,749,297.3725,336,140,321.96
流动负债合计6,203,373,176.266,484,709,122.225,448,288,501.215,797,953,173.74
非流动负债合计590,925,623.98597,151,216.96630,799,269.79656,771,182.54
负债合计6,794,298,800.247,081,860,339.186,079,087,7716,454,724,356.28
归属于母公司股东权益合计19,225,126,390.6419,587,828,435.8419,225,030,179.9518,866,353,649.67
股东权益合计19,235,376,810.119,622,660,932.9219,268,661,526.3718,881,415,965.68
负债和股东权益合计26,029,675,610.3526,704,521,272.125,347,749,297.3725,336,140,321.96
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计7,206,535,143.824,717,435,487.542,077,775,422.412,130,192,039.58
经营活动现金流出小计8,711,354,000.55,342,027,905.712,734,826,079.3311,997,680,959.82
经营活动产生的现金流量净额-1,504,818,856.68-624,592,418.17-657,050,656.93132,511,079.76
投资活动现金流入小计19,037,602,825.478,432,590,927.013,218,668,313.0425,452,928,693.08
投资活动现金流出小计19,923,732,340.878,405,292,284.824,342,461,251.4327,017,765,549.18
投资活动产生的现金流量净额-886,129,515.427,298,642.19-1,123,792,938.39-1,564,836,856.1
筹资活动现金流入小计7,800,0007,800,0007,800,00027,563,455.86
筹资活动现金流出小计337,770,043.23121,881,670.5660,765,585.8689,734,195.64
筹资活动产生的现金流量净额-329,970,043.23-114,081,670.56-52,965,585.8-662,170,739.78
汇率变动对现金及现金等价物的影响-11,731,567.35-5,046,195.91-1,376,815.13-657,997.75
现金及现金等价物净增加额-2,732,649,982.66-716,421,642.45-1,835,185,996.25-2,095,154,513.87
期末现金及现金等价物余额4,797,982,424.516,814,210,764.725,695,446,410.927,530,632,407.17
最新报告期:2024-11-25
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
西部证券陆伏崴1.572.373.012024-11-25
浙商证券孙建1.792.182.752024-11-09
太平洋谭紫媚1.592.313.082024-11-07
兴业证券孙媛媛,黄翰漾1.852.773.392024-11-07
国盛证券杨芳,张金洋1.902.403.022024-11-06
TOP↑